NASDAQ · DH

Definitive Healthcare Corp.

$0.67 -$0.01 (-1.38%) 1D After hours

Key Metrics

$72.07M
Market cap
P/E · TTM
$238.26M
Revenue · TTM
−$170.33M
Net income
EPS · TTM $-1.51
Dividend yield
Free cash flow $27.06M
Beta · 1Y 1.74
EBITDA · TTM −$237.06M
Gross margin 76.0%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 30
    The stock moved +15.7% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 30
  • Jun 25
    From its Feb 2 high, the share price fell 73%.

    Peak close $2.34 on Feb 2; trough close $0.63 on Jun 25. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -73%
  • Jun 25
    The stock moved -17.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 25

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$72.07M
Enterprise value$56.71M
Shares outstanding105.5M
52-wk range$0.62 – $4.70
Avg volume · 20D649.2K
Net cash $15.36M
Book value / share$1.69
IndustryServices-Prepackaged Software
ExchangeNASDAQ
About Definitive Healthcare Corp.
IPO dateSep 15, 2021
Employees686

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.30
P/FCF2.66
EV/EBITDA
EV/Sales0.24
Graham №

Profitability

Gross 76.0%
Operating -101.1%
Net -71.5%
FCF 11.4%
ROE / ROIC -42.7% · -135.9%

Financial Health

Current ratio1.75
Quick ratio
Debt / equity0.85
Debt / EBITDA -0.69
Net cash $15.36M
Working capital$105.35M

Cash Flow · TTM

Operating CF $39.28M
Capex −$12.22M
Free cash flow $27.06M
Buybacks $28.30M
Dividends paid
Shareholder yield 39.3%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-3.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings